First international TNBC conference meeting report

Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies

(2018) Alice Lee et al.   CANCER TREATMENT REVIEWS

Tumor-infiltrating lymphocytes are significantly associated with better overall survival and disease-free survival in triple-negative but not estrogen receptor–positive breast cancers

(2017) Uma Krishnamurti et al.   HUMAN PATHOLOGY

Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, November 30th 2016

(2017) Paolo A. Ascierto et al.   Journal of Translational Medicine

Health Disparities and Triple-Negative Breast Cancer in African American Women

(2017) Lisa A. Newman et al.   JAMA Surgery

What are Health Disparities and Health Equity? We Need to Be Clear

(2017) Paula Braveman   PUBLIC HEALTH REPORTS

Black:white disparities in breast cancer mortality in the 50 largest cities in the United States, 2005–2014

(2016) Bijou R. Hunt et al.   Cancer Epidemiology

New Strategies in Breast Cancer: Immunotherapy

(2016) L. Pusztai et al.   CLINICAL CANCER RESEARCH

Programmed death ligand 1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcome

(2016) Rhiannon K Beckers et al.   HISTOPATHOLOGY

Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis

(2016) Tingting Jiang et al.   PLOS MEDICINE

Expression of Tumor-Related Macrophages and Cytokines After Surgery of Triple-Negative Breast Cancer Patients and its Implications

(2016) Jianguo Wang et al.   MEDICAL SCIENCE MONITOR

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

(2016) Brian D. Lehmann et al.   PLoS One

Methionine Deprivation Induces a Targetable Vulnerability in Triple-Negative Breast Cancer Cells by Enhancing TRAIL Receptor-2 Expression

(2015) E. Strekalova et al.   CLINICAL CANCER RESEARCH

Role of inflammatory infiltrates in triple negative breast cancer: Table 1

(2015) Hirofumi Matsumoto et al.   JOURNAL OF CLINICAL PATHOLOGY

Genome-wide methylation patterns provide insight into differences in breast tumor biology between American women of African and European ancestry

(2015) Christine B. Ambrosone et al.   Oncotarget

Statistical measures of transcriptional diversity capture genomic heterogeneity of cancer

(2014) Tingting Jiang et al.   BMC GENOMICS

Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer

(2014) M. I. Gross et al.   MOLECULAR CANCER THERAPEUTICS

Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes

(2013) H. Masuda et al.   CLINICAL CANCER RESEARCH

Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study

(2013) Ashley Cimino-Mathews et al.   HUMAN PATHOLOGY

Triple-negative breast cancer: new perspectives for novel therapies

(2013) Yashin A. Mahamodhossen et al.   MEDICAL ONCOLOGY

Prognostic impact of FOXP3 expression in triple-negative breast cancer

(2012) Soohyeon Lee et al.   ACTA ONCOLOGICA

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

(2011) Brian D. Lehmann et al.   JOURNAL OF CLINICAL INVESTIGATION